Legacy
-
The former R&Q head of legacy will join as an adviser.
-
The vehicle will give the legacy carrier a US platform.
-
Enstar recorded $280mn of other income in Q1 2023 related to Enhanzed Re.
-
Love joins from Scor, where she was assistant vice president, insurance operations.
-
The legacy deal comes one year after a $1.3bn LPT with Compre covering several lines.
-
The legacy carrier is to buy the captive from a “very large” multinational firm.
-
The agreement from Fleming to honour original terms still leaves it open to long-term damage.
-
Increasingly, deals are being brought to market but not transacted on.
-
R&Q Legacy will book adverse development of ~23% of net reserves for the year.
-
The market is shifting towards capital relief, with fewer, larger deals.
-
The company is still working to get debt holder approval for the Accredited deal.
-
Mitha joined Compre in 2022 as chief actuary, North America.
-
Fleming has claimed breach of contract and is seeking roughly $78mn in “economic concessions”.
-
The company reiterated its commitment to consummating the Accredited sale.
-
The Marco Capital company will target the captives market.
-
Its PE owners have been exploring strategic options since May last year.
-
The newly launched Marco Re will be led by Mark Elliott as CEO.
-
-
CEO Booth said there is “continued interest” in the NA captive market.
-
The transaction would have been one of the largest the market has seen for years.
-
The executive joined the legacy carrier as CIO in 2020.
-
As part of the transaction, Carrick will assume the company’s staff and operations.
-
R&Q is still dealing with a Bermudian regulatory review, personnel turnover and a transitioning business model.
-
Just over half of votes cast were in favour of the $465mn sale to Onex.
-
The legacy carrier has acquired two portfolios of European casualty and motor liabilities from two separate insurance groups.
-
Selling investor Zimmer said the deal was concluded at a premium to book value, but no numbers were disclosed.
-
The regulator has also paused the redemption of the company’s $20mn Tier 2 floating-rate subordinated notes.
-
The R&Q share price has plummeted since the sale of the ~$1.8bn-premium fronting arm was announced 10 days ago.
-
The revised status follows the recent announcement that R&Q Insurance Holdings has agreed a sale of its Accredited program.
-
The bids received did not meet the seller’s reserve price, and it is likely to remarket the unit in two to three years.
-
R&Q expects ongoing operating losses after the sale as transitions its legacy business to a fee-based model.
-
Halfway through a complex restructuring is not the time for a CEO (and CFO) change.
-
R&Q CEO William Spiegel will transfer to the Accredited program management business.
-
Darag’s German outfit completed the transaction to assume expired long-term liability insurance policies from the undisclosed captive.
-
The seller is facing an uphill struggle convincing its legacy rivals that there is strategic value in the merger deal.
-
Although the total deal values for 2022 and 2023 were almost identical, PwC noted that one-third fewer deals were announced in the more recent half-year period.